Part of correspondence recently received from Deanne Miller.
“We are very pleased with all the positive data we have released over the past weeks and continue to remain focused on delivering further results as we advance our pipeline.I’m awaiting clarification from my European colleagues regarding what type of FDA meeting was scheduled for head and neck but know that since we have fast track designation for that indication, we can expect feedback in a matter of weeks regarding avenues to advance in a registrational trial given the very positive data in CPS<1 patients we have shown”
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
24.8¢ |
Change
0.003(1.02%) |
Mkt cap ! $357.7M | |||
| Open | High | Low | Value | Volume |
| 25.0¢ | 25.3¢ | 24.5¢ | $414.7K | 1.683M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 15 | 391650 | 24.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 25.0¢ | 90683 | 10 |
View Market Depth
| Last trade - 11.55am 17/06/2025 (20 minute delay) ? |
| IMM (ASX) Chart |